Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Autor: Youn H Kim, Martine Bagot, Lauren Pinter-Brown, Alain H Rook, Pierluigi Porcu, Steven M Horwitz, Sean Whittaker, Yoshiki Tokura, Maarten Vermeer, Pier Luigi Zinzani, Lubomir Sokol, Stephen Morris, Ellen J Kim, Pablo L Ortiz-Romero, Herbert Eradat, Julia Scarisbrick, Athanasios Tsianakas, Craig Elmets, Stephane Dalle, David C Fisher, Ahmad Halwani, Brian Poligone, John Greer, Maria Teresa Fierro, Amit Khot, Alison J Moskowitz, Amy Musiek, Andrei Shustov, Barbara Pro, Larisa J Geskin, Karen Dwyer, Junji Moriya, Mollie Leoni, Jeffrey S Humphrey, Stacie Hudgens, Dmitri O Grebennik, Kensei Tobinai, Madeleine Duvic, Sunil Abhyankar, Oleg Akilov, Onder Alpdogan, Marie Beylot-Barry, Erin Boh, Dolores Caballero, Richard Cowan, Brigitte Dreno, Reinhard Dummer, Timothy Fenske, Francine Foss, Noriko Fukuhara, Pratyush Giri, Koji Habe, Toshihisa Hamada, Kiyohiko Hatake, Shinsuke Iida, Osamu Ishikawa, Lars Iversen, Eiji Kiyohara, Hiroshi Koga, Neil Korman, Bryone Jean Kuss, Zanetta Lamar, Frederick Lansigan, Mary Jo Lechowicz, Adam Lerner, Nina Magnolo, Lawrence Mark, Tomomitsu Miyagaki, Javier Munoz, Jan Peter Nicolay, Kaoru Nishiwaki, Hiroyuki Okamoto, Mikio Ohtsuka, Theresa Pacheco, Christiane Querfeld, Ronald Peter Rapini, Shigetoshi Sano, Maiko Tanaka, Michael D. Tharp, Jiro Uehara, Hidefumi Wada, Jillian Wells, Ryan A. Wilcox, Basem William, Kentaro Yonekura

Cutaneous T-cell lymphomas are rare non-Hodgkin lymphomas with substantial morbidity and mortality in advanced disease stages. We compared the efficacy of mogamulizumab, a novel monoclonal antibody directed against C-C chemokine receptor 4, with vori

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8475d7d251c9235227444c08d963e299
http://hdl.handle.net/11585/674871

Steroid-Induced Hyperglycemia and Its Effect on Outcomes of R-CHOP Chemotherapy for Diffuse Large B-Cell Lymphoma.

Autor: Kristjanson, Mark^1,2 (AUTHOR) mkristjanson@cancercare.mb.ca, Lambert, Pascal^3,4 (AUTHOR) plambert@cancercare.mb.ca, Decker, Kathleen M.^3,4,5 (AUTHOR) kdecker@cancercare.mb.ca, Bruin, Sonja⁶ (AUTHOR) sonja.bruin@umanitoba.ca, Tingey, Elizabeth⁷ (AUTHOR) tingeye@myumanitoba.ca, Skrabek, Pamela^8,9 (AUTHOR) pskrabek@cancercare.mb.ca

Publikováno v: Current Oncology. Dec2023, Vol. 30 Issue 12, p10142-10151. 10p.

Ibrutinib and rituximab induced rapid response in refractory Richter syndrome.

Autor: Lamar, Zanetta¹, Kennedy, LeAnne², Kennedy, Brooke¹, Lynch, Mary¹, Goad, Amanda¹, Hurd, David¹, McIver, Zachariah¹

Publikováno v: Clinical Case Reports. Jul2015, Vol. 3 Issue 7, p615-617. 3p.

Highlights From the Circulation Family of Journals.

Publikováno v: Circulation; 9/4/2018, Vol. 138 Issue 10, p1054-1059, 6p

Management of meningeal neoplasms: meningiomas and hemangiopericytomas.

Autor: Lamar, Zanetta, Lesser, Glenn, Lesser, Glenn J

Publikováno v: Current Treatment Options in Oncology; Sep2011, Vol. 12 Issue 3, p230-239, 10p